Receptor-Interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer

To identify druggable regulators of immunosuppressive tumor immune microenvironment, researchers performed a kinome- and membranome-focused CRISPR screening using orthotopic PDAC models.